These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17077546)

  • 1. Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use.
    Qi H; Li L; Huang C; Li W; Wu C
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1500-7. PubMed ID: 17077546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery.
    Kim EY; Gao ZG; Park JS; Li H; Han K
    Int J Pharm; 2002 Feb; 233(1-2):159-67. PubMed ID: 11897420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of additives on the physicochemical properties of liquid suppository bases.
    Choi H; Lee M; Kim M; Kim C
    Int J Pharm; 1999 Nov; 190(1):13-9. PubMed ID: 10528092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium.
    Yong CS; Choi JS; Quan QZ; Rhee JD; Kim CK; Lim SJ; Kim KM; Oh PS; Choi HG
    Int J Pharm; 2001 Sep; 226(1-2):195-205. PubMed ID: 11532582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
    Lihong W; Xin C; Yongxue G; Yiying B; Gang C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate].
    Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM
    Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydroxypropyl beta-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407.
    Bonacucina G; Spina M; Misici-Falzi M; Cespi M; Pucciarelli S; Angeletti M; Palmieri GF
    Eur J Pharm Sci; 2007 Oct; 32(2):115-22. PubMed ID: 17656076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration.
    Arbelaez-Camargo D; Suñé-Negre JM; Roig-Carreras M; García-Montoya E; Pérez-Lozano P; Miñarro-Carmona M; Ticó-Grau JR
    Int J Pharm; 2016 Feb; 498(1-2):142-52. PubMed ID: 26685726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
    Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
    Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of diclofenac sodium-loaded poloxamer gel as a rectal delivery system with fast absorption.
    Yong CS; Sah H; Jahng Y; Chang HW; Son JK; Lee SH; Jeong TC; Rhee JD; Baek SH; Kim CK; Choi HG
    Drug Dev Ind Pharm; 2003 May; 29(5):545-53. PubMed ID: 12779284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.
    Zhou Q; Zhong L; Wei X; Dou W; Chou G; Wang Z
    Int J Pharm; 2013 Sep; 454(1):125-34. PubMed ID: 23850236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
    Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
    Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies.
    Wei G; Xu H; Ding PT; Li SM; Zheng JM
    J Control Release; 2002 Sep; 83(1):65-74. PubMed ID: 12220839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimization of ligustrazine phosphate thermosensitive gel formulation by central composite design-response surface methodology].
    Meng DM; Xu YH; Ding PT; Deng YJ; Wei MY
    Zhong Yao Cai; 2008 Feb; 31(2):286-8. PubMed ID: 18619280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of thermoreversible poloxamer gel system using QbD principle.
    Ban E; Jang DJ; Kim SJ; Park M; Kim A
    Pharm Dev Technol; 2017 Nov; 22(7):939-945. PubMed ID: 27480338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use.
    Edsman K; Carlfors J; Petersson R
    Eur J Pharm Sci; 1998 Apr; 6(2):105-12. PubMed ID: 9795025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
    Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
    Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.